» Articles » PMID: 24896812

Endothelial Depletion of Acvrl1 in Mice Leads to Arteriovenous Malformations Associated with Reduced Endoglin Expression

Overview
Journal PLoS One
Date 2014 Jun 5
PMID 24896812
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Rare inherited cardiovascular diseases are frequently caused by mutations in genes that are essential for the formation and/or function of the cardiovasculature. Hereditary Haemorrhagic Telangiectasia is a familial disease of this type. The majority of patients carry mutations in either Endoglin (ENG) or ACVRL1 (also known as ALK1) genes, and the disease is characterized by arteriovenous malformations and persistent haemorrhage. ENG and ACVRL1 encode receptors for the TGFβ superfamily of ligands, that are essential for angiogenesis in early development but their roles are not fully understood. Our goal was to examine the role of Acvrl1 in vascular endothelial cells during vascular development and to determine whether loss of endothelial Acvrl1 leads to arteriovenous malformations. Acvrl1 was depleted in endothelial cells either in early postnatal life or in adult mice. Using the neonatal retinal plexus to examine angiogenesis, we observed that loss of endothelial Acvrl1 led to venous enlargement, vascular hyperbranching and arteriovenous malformations. These phenotypes were associated with loss of arterial Jag1 expression, decreased pSmad1/5/8 activity and increased endothelial cell proliferation. We found that Endoglin was markedly down-regulated in Acvrl1-depleted ECs showing endoglin expression to be downstream of Acvrl1 signalling in vivo. Endothelial-specific depletion of Acvrl1 in pups also led to pulmonary haemorrhage, but in adult mice resulted in caecal haemorrhage and fatal anaemia. We conclude that during development, endothelial Acvrl1 plays an essential role to regulate endothelial cell proliferation and arterial identity during angiogenesis, whilst in adult life endothelial Acvrl1 is required to maintain vascular integrity.

Citing Articles

From bench to bedside: murine models of inherited and sporadic brain arteriovenous malformations.

Ricciardelli A, Genet G, Genet N, McClugage 3rd S, Kan P, Hirschi K Angiogenesis. 2025; 28(2):15.

PMID: 39899215 PMC: 11790818. DOI: 10.1007/s10456-024-09953-5.


Genetic and pharmacological targeting of mTORC1 in mouse models of arteriovenous malformation expose non-cell autonomous signalling in HHT.

Queiro-Palou A, Jin Y, Jakobsson L Angiogenesis. 2024; 28(1):6.

PMID: 39661206 PMC: 11634917. DOI: 10.1007/s10456-024-09961-5.


Alk1/Endoglin signaling restricts vein cell size increases in response to hemodynamic cues.

Diwan Z, Kang J, Tsztoo E, Siekmann A Angiogenesis. 2024; 28(1):5.

PMID: 39656297 PMC: 11632009. DOI: 10.1007/s10456-024-09955-3.


Inhibition of endothelial cell proliferation as a potential therapeutic approach in hereditary hemorrhagic telangectasia.

Ricard N, Bailly S Nat Cardiovasc Res. 2024; 3(11):1267-1269.

PMID: 39487365 DOI: 10.1038/s44161-024-00557-2.


CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia.

Dinakaran S, Qutaina S, Zhao H, Tang Y, Wang Z, Ruiz S Nat Cardiovasc Res. 2024; 3(11):1301-1317.

PMID: 39487364 PMC: 11651362. DOI: 10.1038/s44161-024-00550-9.


References
1.
Fernandez-L A, Sanz-Rodriguez F, Zarrabeitia R, Perez-Molino A, Hebbel R, Nguyen J . Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions. Cardiovasc Res. 2005; 68(2):235-48. DOI: 10.1016/j.cardiores.2005.06.009. View

2.
Young K, Conley B, Romero D, Tweedie E, ONeill C, Pinz I . BMP9 regulates endoglin-dependent chemokine responses in endothelial cells. Blood. 2012; 120(20):4263-73. PMC: 3501721. DOI: 10.1182/blood-2012-07-440784. View

3.
Alt A, Miguel-Romero L, Donderis J, Aristorena M, Blanco F, Round A . Structural and functional insights into endoglin ligand recognition and binding. PLoS One. 2012; 7(2):e29948. PMC: 3275592. DOI: 10.1371/journal.pone.0029948. View

4.
Sanz-Rodriguez F, Fernandez-L A, Zarrabeitia R, Perez-Molino A, Ramirez J, Coto E . Mutation analysis in Spanish patients with hereditary hemorrhagic telangiectasia: deficient endoglin up-regulation in activated monocytes. Clin Chem. 2004; 50(11):2003-11. DOI: 10.1373/clinchem.2004.035287. View

5.
Chen W, Guo Y, Walker E, Shen F, Jun K, Oh S . Reduced mural cell coverage and impaired vessel integrity after angiogenic stimulation in the Alk1-deficient brain. Arterioscler Thromb Vasc Biol. 2012; 33(2):305-10. PMC: 3569037. DOI: 10.1161/ATVBAHA.112.300485. View